An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT02305563 · TERMINATED
Trial details
- NCT number
- NCT02305563
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-27
- Primary completion
- 2019-06-04
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.